J. Benzaquen

发表

Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?

Daniel J Klionsky, Paul Hofman, D. Klionsky, 2020, Autophagy.

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France

C. Marquette, S. Leroy, J. Mazières, 2017, BMJ Open.

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test

C. Marquette, S. Leroy, P. Brest, 2021, Microbiology spectrum.

Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).

C. Marquette, S. Leroy, E. Selva, 2020, Biopreservation and biobanking.

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of Translational Medicine.

Autophagy-Modulating Drugs in the SARS-CoV-2 War Open Questions for Harnessing

D. Klionsky, P. Brest, J. Benzaquen, 2020 .

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

C. Marquette, S. Leroy, J. Benzaquen, 2018, Cancers.

Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer.

C. Marquette, J. Thariat, J. Mazières, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Purinergic Landscape of Non-Small Cell Lung Cancer

J. Benzaquen, P. Hofman, V. Vouret-Craviari, 2022, Cancers.

P2RX7B is a new theranostic marker for lung adenocarcinoma patients

S. Saccani, C. Marquette, S. Leroy, 2020, Theranostics.

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2022, Cancers.

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)

C. Marquette, S. Leroy, R. Schiappa, 2022, Frontiers in Medicine.

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables

C. Marquette, S. Leroy, Y. Diascorn, 2019, BMC pulmonary medicine.

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).

C. Marquette, S. Leroy, M. Denis, 2019, Clinical lung cancer.

A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracy

C. Marquette, S. Leroy, G. Troncone, 2021, Annals of translational medicine.

Title: Clinical performance of oral sponge sampling for detection by RT-PCR of SARS-CoV-2

C. Marquette, S. Leroy, J. Benzaquen, 2021 .

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay

C. Marquette, J. Thariat, J. Mazières, 2020, Annals of translational medicine.

Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation.

D. Shahbazian, J. Benzaquen, P. Hofman, 2020, JCO precision oncology.

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).

C. Marquette, F. Barlesi, J. Benzaquen, 2020, Lung cancer.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study

C. Marquette, J. Vergnon, S. Leroy, 2017, European Respiratory Journal.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)

A. Cuvelier, N. Roche, C. Marquette, 2018, Respiratory Research.

Brief Report: Comparison of three sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer demonstrates low comparability.

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2020, medRxiv.

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

Dingxie Liu, J. Benzaquen, P. Hofman, 2022, Cancers.

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches

C. Marquette, J. Benzaquen, P. Hofman, 2022, Journal of personalized medicine.

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing

C. Marquette, J. Benzaquen, P. Hofman, 2022, Journal of personalized medicine.

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer

C. Marquette, P. Brest, J. Benzaquen, 2022, Clinical and translational medicine.

Allergy evaluation of hypersensitivity to platinium salts and taxanes: a six-year experience.

C. Marquette, S. Leroy, P. Follana, 2020, The journal of allergy and clinical immunology. In practice.

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients

A. Stenzinger, C. Marquette, J. Benzaquen, 2019, Cancers.

[The biological rationale for immunotherapy in cancer].

C. Marquette, S. Leroy, N. Glaichenhaus, 2018, Revue des maladies respiratoires.

To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question

J. Benzaquen, P. Hofman, V. Vouret-Craviari, 2021, Purinergic Signalling.

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

C. Marquette, J. Benzaquen, P. Hofman, 2019, Biomedical journal.

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

N. Ayache, C. Marquette, J. Benzaquen, 2022, Cancers.

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

A. Hofman, S. Cajal, P. Brousset, 2020, ESMO Open.

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of Translational Medicine.

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.

C. Marquette, R. Schiappa, J. Benzaquen, 2020, Bulletin du cancer.

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing

C. Marquette, S. Leroy, J. Benzaquen, 2021, ERJ Open Research.

Clinical performance of oral sponge sampling for detection by RT-PCR of SARS-CoV-2

C. Marquette, S. Leroy, E. Selva, 2021, medRxiv.

Multidisciplinary management of tracheobronchial injury

C. Marquette, S. Leroy, J. Benzaquen, 2022, European Respiratory Review.

Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities.

C. Marquette, S. Leroy, J. Benzaquen, 2018, Current molecular medicine.

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC

P. Brousset, C. Marquette, J. Mazières, 2022, JTO clinical and research reports.

Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2022, Lung cancer.

A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy

B. Ryffel, J. Kanellopoulos, J. Benzaquen, 2021, Nature Communications.

Small-molecule P2RX7 activator sensitizes tumor to immunotherapy and vaccinates mouse against tumor re-challenge

B. Ryffel, J. Kanellopoulos, J. Benzaquen, 2020, bioRxiv.

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2020, Cancers.

Changes in dynamic lung mechanics after lung volume reduction coil treatment of severe emphysema

C. Marquette, S. Zakynthinos, S. Leroy, 2017, Thorax.

Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients

S. Besset, T. Similowski, S. Jaber, 2022, American journal of respiratory and critical care medicine.

Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study

J. Darcourt, R. Schiappa, J. Benzaquen, 2020, Journal for ImmunoTherapy of Cancer.

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

C. Marquette, J. Benzaquen, P. Hofman, 2021, Frontiers in Pharmacology.

Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.

C. Marquette, J. Benzaquen, P. Hofman, 2023, Lung cancer.

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

C. Marquette, C. Pison, J. Benzaquen, 2020, The Lancet. Respiratory medicine.

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer

C. Marquette, P. Bondiau, R. Schiappa, 2023, Radiation Oncology.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

C. Marquette, J. Mazières, J. Sabourin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

C. Marquette, S. Leroy, J. Benzaquen, 2023, International journal of molecular sciences.

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?

Paul Hofman, C. Marquette, J. Benzaquen, 2019, Cancers.

Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial

M. Copin, P. Birembaut, L. Thiberville, 2022, European Respiratory Journal.

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients

C. Czerkinsky, S. Leroy, J. Benzaquen, 2021, medRxiv.

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)

L. Xerri, C. Marquette, J. Benzaquen, 2023, Journal of personalized medicine.

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects

C. Marquette, N. Glaichenhaus, J. Benzaquen, 2022, medRxiv.